---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-237218"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:25:11.370309+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CareDx reports preliminary Q3 revenue of $82-83M, up 23% YoY; testing volume rises 16%

## Summary
- Preliminary Q3 2024 revenue $82-83M, up ~23% YoY; testing services $60-61M (+26%).
- Testing volume ~44,600 tests, up ~16% YoY; includes $1.2M from prior quarters.
- Patient & Digital Solutions rev ~$11.9M (+20%); Products rev ~$10.2M (+7%).
- Cash and marketable securities ~$240M, no debt; strong balance sheet.
- Full Q3 results to be reported on November 4, 2024.

## SEC filing metadata
- accession: 0001193125-24-237218
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000119312524237218/0001193125-24-237218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000119312524237218/d889373d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-237218
- JSON: https://secwatch.observer/filing/0001193125-24-237218.json
- Plain text: https://secwatch.observer/filing/0001193125-24-237218.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.